Immunosuppressive effects of melanoma-derived heavy-chain ferritin are dependent on stimulation of IL-10 production

International Journal of Cancer

Volumn 92, Issue 6, 2001, Pages 843-850

  Gray, Christian P ^a   Franco, Agustin V ^a   Arosio, P ^b   Hersey, Peter ^a,c  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c David Maddison Clin Sci Building   (Australia)

Author keywords

Heavy chain ferritin; Human melanoma; IL 10; Immunosuppression; Light chain ferritin; SEREX

Indexed keywords

CD3 ANTIGEN; COMPLEMENTARY DNA; FERRITIN; HEAVY CHAIN FERRITIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LIGHT CHAIN FERRITIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA LIBRARY; DNA SEQUENCE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; MELANOMA; MITOGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION; SCREENING; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; BASE SEQUENCE; BLOTTING, WESTERN; DIMERIZATION; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRITINS; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LIVER; LYMPHOCYTES; MELANOMA; MOLECULAR SEQUENCE DATA; MYOCARDIUM; PLASMIDS; PRECIPITIN TESTS; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; T-LYMPHOCYTES; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0035876972     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1269     Document Type: Article

References (55)

1. Roth JA, Grimm EA, Gupta RK, Ames RS. Immunoregulatory factors derived from human tumors. J Immunol 1982;128:1955-62.
2. Brotherick I, Shenton BK, Kirby JA, Rigg JM, Palmer JM, Yeaman SJ, et al. Production of immunosuppressive factors by a cultured tumour cell line and their effect on lymphocyte proliferation. Surg Oncol 1993;2:241-8.
3. Bailet JW, Lichtenstein A, Chen G, Michel RA. Inhibition of lymphocyte function by head and neck carcinoma cell line soluble factors. Arch Otolaryngol Head Neck Surg 1997;123:855-62.
4. 2 induced changes in the phenotype, morphology, and lytic activity of IL-2 activated natural killer cells. J Immunol 1993;150:3747-54.
5. Bodmer S, Strommer K, Frei K, Siepl C, De Tribolet N, Heid I, et al. Immunosuppression and transforming growth factor-β in glioblastoma. J Immunol 1989;143:3222-9.
6. Roszman T, Elliott L, Brooks W. Modulation of T-cell function by gliomas. Immunol Today 1991;12:370-4.
7. Matsuda M, Salazar F, Petersson M, Musucci G, Hansson J, Pisa P, et al. Interleukin 10 pretreatment protects target cells from tumor and allo-specific cytotoxic T cells and down regulates HLA class I expression. J Exp Med 1994;180:2371-6.
8. 4+ T cells. J Exp Med 1996;184:19-29.
9. Tilg TS, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators, Immunol Today 1997;18:428-32.
10. Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, Wasserman K, et al. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell and natural killer cell-mediated cytotoxicity. Eur J Immunol 1996;26:1313.
11. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996;184:1082.
12. Matzner Y, Hershko C, Polliack A, Konjin AM, Izak G. Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol 1979;42:345-53.
13. Matzner Y, Konjin AM, Shlomai Z, Ben-Bassat H. Differential effect of isolated placental isoferritins on in vitro T-lymphocyte function. Br J Haematol 1985;59:443-8.
14. Rosen HR, Ausch C, Reinerova M, Zaspin E, Renner K, Rosen AC, et al. Activated lymphocytes from breast cancer patients express the characteristic of type 2 helper cells - a possible role for breast cancer-associated p43. Cancer Lett 1998;127:129-34.
15. Wigginton JM. Reversal of ferritin-mediated immunosuppression by levamisole: a rationale for its application to management of the acquired immune deficiency syndrome (AIDS). Med Hypotheses 1995;44:85-8.
16. Broxmeyer HE, Lu L, Bicknell DC, Williams DE, Cooper S, Levi S, et al. The influence of purified recombinant human heavy-subunit and light-subunit ferritins on colony formation in vitro by granulocyte-macrophage and erythroid progenitor cells. Blood 1986;68:1257-63.
17. Hann H, Levy HM, Evans AE. Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res 1980;40:1413.
18. Arosio P, Adelman TG, Drysdale JW. On ferritin heterogeneity: further evidence for heteropolymers. J Biol Chem 1979;253:4451-8.
19. Theil EC. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 1987;56: 285-315.
20. McGill JR, Naylor SL, Sakaguchi AY, Moore CM, Boyd D, Barrett K, et al. Human ferritin H and L sequences lie on ten different chromosomes. Hum Genet 1987;76:66-72.
21. Morikawa K, Oseko F, Morikawa S. A role for ferritin in hematopoiesis and the immune system. Leukemia Lymphoma 1995;18:429-33.
22. Hazard JT, Drysdale JW. Ferritinaemia in cancer. Nature 1977;265: 755-6.
23. Constanzo F, Colombo M, Staempfli S, Santoro C, Marone M, Frank R, et al. Structure of gene and pseudogenes of human apoferritin H. Nucleic Acids Res 1986;14:721-36.
24. r 43,000 peptide associated with ferritin in human leukemia K562 cells and its down regulation during differentiation. Cancer Res 1989;49:5033-6.
25. Zhang X, Franco A, Myers K, Gray C, Nguyen T, Hersey P. Relation of TRAIL receptor and FLIP expression to TRAIL induced apoptosis of melanoma. Cancer Res 1999;59:2747-53.
26. Curry BJ, Myers K, Hersey P. Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma. J Clin Oncol 1998;16: 1760-9.
27. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
28. Corsi B, Perrone F, Bourgeois M, Beaumont C, Panzeri MC, Cozzi A, et al. Transient over expression of human H- and L-ferritin in COS cells. J Biol Chem 1998;330:315-20.
29. Chen Q, Daniel V, Maher DW, Hersey P. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer 1994;56:755-60.
30. Smith M, Bleijs R, Radford K, Hersey P. Immunogenicity of CD63 in a patient with melanoma. Melanoma Res 1997;7:S163-70.
31. Constanzo F, Santoro C, Colantuoni V, Bensi G, Raugei G, Romano V, et al. Cloning and sequencing of a full length cDNA coding for a human apoferritin H chain: evidence for a multigene family. EMBO J 1984;3:23-7.
32. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 1992;258:1808-12.
33. Ausubel F, Brent R, Kingston RE, Moore DD, Seidman JG, Struhl K. Short protocols in molecular biology: a compendium of methods from current protocols in molecular biology. New York: John Wiley & Sons, 1995.
34. Sharrow CO. Analysis of flow cytometry data. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology. New York: John Wiley & Sons, 1996.
35. Hersey P, Bindon C, Czerniecki M, Spurling A, Wass J, McCarthy WH. Inhibition of interleukin 2 production by factors released from tumor cells. J Immunol 1983;131:2837-42.
36. Boyd D, Vecoli C, Belcher DM, Jain SK, Drysdale JW. Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. J Biol Chem 1985;260:11755-61.
37. Dhar M, Chauthaiwale V, Joshi JG. Sequence of a cDNA encoding the ferritin H-chain from an 11-week-old human fetal brain. Gene 1993;126:275-8.
38. Ai LS, Chau LY. Post-transcriptional regulation of H-ferritin mRNA. Identification of a pyrimidine-rich sequence in the 3′-untranslated region associated with message stability in human monocytic thp-1 cells. J Biol Chem 1999;274:30209-14.
39. Cavanna F, Ruggeri G, Iacobello C, Chieregatti G, Murador E, Albertini A, et al. Development of a monoclonal antibody against human heart ferritm and its application in an immunoradiometric assay. Clin Chim Acta 1983;134:347-56.
40. Dezza L, Cazzola M, Bergamaschi G, Stella CC, Pedrazzoli P, Recalde HR. Effects of recombinant human H-subuntt and L-subunit ferritins on in vitro growth of human granulocytes-monocyte progenitors. Br J Haematol 1988;68:367-72.
41. Schraven B, Marie-Cardine A, Hübener C, Bruyns E, Ding I. Integration of receptor-mediated signals in T cells by transmembrane adaptor proteins. Immunol Today 1999;20:431-4.
42. Goto S, Sato M, Kaneko R, Itoh M, Sato S, Takeuchi S. Analysis of TH1 and TH2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunol Immunother 1999;48:435-42.
43. Santambrogio P, Levi S, Cozzi A, Rovidia E, Albertini A, Arosio P. Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem 1993;268:12744-8.
44. Moroz C, Shterman N, Kupfer B, Ginzburg I. T-cell mitogenesis stimulates the synthesis of a mRNA species coding for a 43-kDa peptide reactive with CH-H-9, a monoclonal antibody specific for placental isoferritin. Proc Natl Acad Sci USA 1989;86:3282-5.
45. Tripathi PK, Chatterjee SK. Elevated expression of ferritin H-chain mRNA in metastatic ovarian tumor. Cancer Invest 1996;14:518-26.
46. Luger TA, Linkesch W, Knobler R, Kokoschka EM. Serial determination of serum ferritin levels in patients with malignant melanoma. Oncology 1983;40:263-7.
47. Iancu TC, Shiloh H, Kedar A. Neuroblastomas contain iron-rich ferritin. Cancer 1988;61:2497-502.
48. Partin AW, Criley SR, Steiner MS, Hsieh K, Simons JW, Lumadue J, et al. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. Urology 1995;45:211-7.
49. Fargion S, Fracanzani AL, Brando B, Arosio P, Fiorelli G. Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood 1991;78:1056-61.
50. Moss D, Fargion S, Fracanzani AL, Levi S, Cappellini MD, Arosio P, et al. Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. J Inorg Biochem 1992;47:219-27.
51. + T cells with immunoregulatory properties. Allergy Clin Immunol 2000;106:S109-12.
52. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.
53. + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific TH1 immune responses. J Invest Dermatol 2000;14:295-302.
54. De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, Velde A, Figdor C. et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 1991;174: 915-24.
55. Needleman SB, Wunsch CD. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 1970;44:443-53.